Clinical Trials Browser

Carcinoma, Neuroendocrine

Esophageal Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Neuroendocrine Tumors

Pancreatic Ductal Adenocarcinoma

Colonic Neoplasms

Thyroid Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Brain Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neoplasms, Plasma Cell

Carcinoma, Neuroendocrine

Liver Malignancy

Disease, Pancreatic Neoplasms

Large B-cell Lymphoma

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Smoking Cessation, Multiple Pulmonary Nodules

Glioma, Parkinson Disease, Prostatic Neoplasms

Adenocarcinoma, Stomach Neoplasms

Hodgkin Disease, Lymphoma

Neuroendocrine Tumors

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Sarcoma, Osteosarcoma

Breast Neoplasms

Hodgkin Disease, Lymphoma

Lymphoma, B-Cell, Lymphoma, T-Cell

Lung Neoplasms

Multiple Myeloma

Neuroendocrine Tumors

Neuroendocrine Tumors

Hepatic Malignancies

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Neuroendocrine Tumors

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Prostatic Neoplasms

Multiple Myeloma

Breast Cancer Metastases

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Cancer Diagnosis

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Prostatic Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Neuroendocrine Tumors

Clinical Trials

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Colon Cancer Diagnosis With FAPI-PET Imaging

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

CONPET

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

68Ga-FAPI PET/CT in Malignant Tumors

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

Biomarkers to Detect Endocrine Therapy Resistance

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

BURGUND

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

qMAP

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

PET/MR Imaging in Lung Cancer

A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

PIPPIN

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients

First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

HENEPET

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

PSMA PET

REPEAT

WHENII

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors